论文部分内容阅读
目的:观察复方阿嗪米特联合伊托必利对功能性消化不良的疗效。方法:160例功能性消化不良患者根据就诊次序随机分为治疗组和对照组,治疗组应用复方阿嗪米特片,2片,po,tid,同时用伊托必利胶囊,50 mg,po,tid;对照组应用伊托必利胶囊,50 mg,po,tid,疗程均为4周;观察临床症状变化。结果:在14,28 d,治疗组和对照组2组中总有效率分别为85.0%,90.0%;63.8%,67.5%,治疗组和对照组比较差异有统计学意义(P<0.05)。结论:复方阿嗪米特联合伊托必利治疗功能性消化不良疗效显著,无明显不良反应。
Objective: To observe the curative effect of compound azinamid combined with itopride on functional dyspepsia. Methods: One hundred and sixty patients with functional dyspepsia were randomly divided into treatment group and control group according to the order of treatment. The patients in the treatment group were given compound azintomide tablets, 2 tablets, po, tid, , tid; control group, itopride capsules, 50 mg, po, tid, treatment were 4 weeks; observed changes in clinical symptoms. Results: At 14 and 28 days, the total effective rates in the two groups were 85.0%, 90.0%, 63.8% and 67.5%, respectively. The difference between the two groups was statistically significant (P <0.05). Conclusion: The combination of compound azintomide and itopride has significant curative effect on functional dyspepsia without obvious adverse reactions.